Key result
LPCAT3 and ELOVL5 activity is linked to more stable carotid plaques and lower stroke risk.
Why the study?
Does the inactivation of ELOVL5 and LPCAT3 in macrophages increase atherosclerotic plaque vulnerability?
Does the inactivation of ELOVL5 and LPCAT3 in macrophages increase atherosclerotic plaque vulnerability?
Answers are grounded in this paper and cite their sources.
PUFA-containing ether lipids generated by LPCAT3 and ELOVL5 promote atherosclerotic plaque stability and may serve as biomarkers and therapeutic targets.
Essential fatty acid metabolism in myeloid cells plays a critical but underexplored role in immune function. Here, we demonstrate that simultaneous inactivation of two key enzymes involved in macrophage polyunsaturated fatty acid (PUFA) metabolism-ELOVL5, which elongates long-chain PUFAs, and LPCAT3, which incorporates them into phospholipids-disrupts membrane organization by promoting the formation of cholesterol-enriched domains. This increases macrophage sensitivity to cytotoxic oxysterols and leads to more vulnerable atherosclerotic plaques with enlarged necrotic cores in a mouse model of atherosclerosis. In humans, analysis of 187 carotid plaques reveals a positive correlation between LPCAT3/ELOVL5-generated phospholipids-including arachidonate (C20:4 n-6)-containing ether lipids-and more stable plaque profiles. Additionally, Mendelian randomization analysis supports a causal relationship between LPCAT3 expression and reduced risk of ischemic stroke. Our findings uncover a regulatory circuit essential for PUFA-containing phospholipid generation in macrophages, positioning PUFA-containing ether lipids as promising biomarkers and therapeutic targets.
No takes yet. Share an insight, caveat, or question.
Jalil et al. (2025) studied Atherosclerosis (n=187). LPCAT3 expression and LPCAT3/ELOVL5-generated phospholipids was evaluated on Plaque stability and ischemic stroke risk. LPCAT3/ELOVL5-generated phospholipids correlated with more stable human carotid plaques, and Mendelian randomization linked LPCAT3 expression to a reduced risk of ischemic stroke.
Synapse has enriched 10 related papers. Consider them for comparative context: